Team 2

Autonomous Guidewire and Catheter Insertion Device

Team Members: James Crichton
Jacqueline Klier
Charmayne Seaton
Summer Suttell

Team Mentors: Kuei-Chun (Mark) Wang, PhD - SBHSE
Scott Beeman, PhD - SBHSE
James Bogert, MD - Dignity Health

YouTube Link: View the video link below before joining the zoom meeting

Zoom Link: https://asu.zoom.us/j/81964869962

Abstract

The current method clinicians use to cannulate the femoral vein is through a procedure known as the Seldinger Technique. This technique was introduced by Swedish radiologist in 1953 and has since been critiqued and modified. Decades later the technique is still a hassle to perform and still has routine complications including thrombosis, catheter migration, puncture site infection, and even injury to the femoral nerve. Assuming that vascular access had already been acquired, our device will cannulate the femoral vein with just the press of a button. Autonomizing this process will allow a lower trained medical staff to perform the procedure. This will allow physicians to tend to more patients and hopefully provide patients with a more comfortable experience. Utilizing the needle already placed in the patient’s femoral vein, our device will insert a guidewire and then place the catheter allowing staff to administer medication, perform volume infusions, blood draws, and interventional procedures. With our device, the team hopes to minimize cannulation inaccuracies and relieve the burden placed on physicians to perform the procedure which is often a necessity in chaotic settings. With regards to marketing, this device would fall into the peripheral vascular market segment. The peripheral vascular market includes veins and arteries not in the chest or abdomen. Currently, this market has a compound annual growth rate (CAGR) of 8.7% and annual revenue of roughly 8 billion dollars. This market is continuously growing due to the rapid growth of peripheral vascular diseases and the growing geriatric population. Our target market includes hospitals and healthcare clinics, but could be utilized in any clinical setting where central venous access can be achieved.